- Searches for six popular peptides exceed 3.9m monthly with growth up to 6,407pc
- Travelers carrying research peptides risk confiscation, claim rejection and criminal prosecution
- Products labelled research use only are not approved for personal treatment
- Official guidance warns travelers could be fined or imprisoned
- Australia has issued a specific warning about importing unapproved peptide products
Travellers carrying research peptides across international borders risk having products confiscated, related travel-insurance claims rejected and in serious cases criminal prosecution, according to new analysis by Licensed Peptides. Searches for six popular peptides now exceed 3.9m a month, with annual search growth reaching as high as 6,407pc. Retatrutide alone receives 2.8m monthly searches, an increase of 979pc over the past year, while searches for CJC-1295 have risen by 1,041pc.
Products labelled research use only are not medicines approved for personal treatment, with Samuel Sarmiento, physician and medical content reviewer for Licensed Peptides, confirming that travelers may wrongly assume that being able to purchase a peptide online means it can be legally carried abroad or will be covered by travel insurance. A claim connected to someone carrying or personally using a non-prescribed or unapproved product could be investigated and potentially rejected under the policy’s drug-use, illegal-activity, experimental-treatment or pre-existing-condition exclusions. The traveler could then face two separate problems: action from customs authorities and an insurer refusing to pay the resulting costs.
Travelers could face legal consequences if a peptide is prohibited, restricted or cannot lawfully be imported into their destination, with authorities able to confiscate and destroy the product, issue a financial penalty, detain or question the traveler, investigate suspected illegal importation, bring criminal charges or impose a prison sentence in serious cases. Official guidance warns that travelers could be fined or imprisoned for carrying medicine that is illegal in another country and advises them to check directly with the destination’s embassy. Australia’s Therapeutic Goods Administration has issued a specific warning about importing unapproved peptide products.
Samuel Sarmiento, physician and medical content reviewer for Licensed Peptides, shared: “A ‘research use only’ label is not a passport, prescription or import permit, and travelers may wrongly assume that being able to purchase a peptide online means it can be legally carried abroad or will be covered by travel insurance. A claim connected to someone carrying or personally using a non-prescribed or unapproved product could be investigated and potentially rejected under the policy’s drug-use, illegal-activity, experimental-treatment or pre-existing-condition exclusions.”
Travel Extra shared: “The Australian regulator says products imported unlawfully may be seized and destroyed, while serious cases of illegal medicine importation can result in fines or imprisonment.”
